Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
Blood Products Advisory Committee considers at-home HIV test; Protica QC personnel fail on supplement GMPs; FDA warns pregnancy test maker of GMP, labeling violations; FDA uncovers more tainted supplements sold online; NRDC request for BPA ban short on data.
You may also be interested in...
In Brief
OTC HIV tests inch closer; FDA investigates Plan B vending machine; Crest toothpaste brightens in one use; L’Oreal sues J&J, Merck for sunscreen patent infringement; more News In Brief.
FDA Shift On BPA May Tighten Squeeze On Infant Formula Manufacturers
FDA's shift in position regarding the safety of bisphenol A likely will expedite the trend toward BPA-free packaging among infant formula marketers, even though existing science does not demonstrate a proven threat to babies and children
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.